文献速递神经CT

RapidAI与Viz.ai软件在急性缺血性卒中评估中CT灌注输出结果的比较

A Comparison of CT Perfusion Output of RapidAI and Viz.ai Software in the Evaluation of Acute Ischemic Stroke.
PubMed 文献 · AJNR Am J Neuroradiol · 2024-07-08

本研究分析了129例急性缺血性卒中患者的CT灌注(CTP)数据,分别用RapidAI与Viz.ai软件处理,比较两种软件在早期(<6小时)和延长时间窗(>6小时)的决策规则及输出结果的一致性,并寻找灌注CT研究质量不足的预测因素。结果显示108例质量合格,两种软件各灌注参数相关性中等至良好但存在统计学差异,Viz.ai预测的缺血核心体积更大,但按DAWN和DEFUSE 3标准筛选患者的分类结果等效。射血分数较低可预测两种软件的研究质量不足。

要点

  • Viz.ai预测的缺血核心体积(CBF<30%)大于RapidAI,差异有统计学意义(P<.001)。
  • 两种软件按DAWN和DEFUSE 3标准筛选患者的分类结果等效,无临床显著差异。
  • 射血分数较低可预测两种软件的研究质量不足。

核心结论

  • RapidAI与Viz.ai对缺血半暗带和梗死核心的预测相关但存在统计学差异,按DAWN和DEFUSE 3标准分诊结果等效;Viz.ai预测的缺血核心体积更大,在较低体积时预测的核心加半暗带总和低于RapidAI,在较高体积时高于RapidAI;临床医生使用不同软件包进行临床决策时应谨慎。

研究设计与样本

  • 研究纳入129例急性缺血性卒中患者,就诊时行CTP检查,分别用RapidAI和Viz.ai软件分析,采用Spearman秩相关和Wilcoxon符号秩检验比较体积输出,并在早期(<6小时)和延长时间窗(>6小时)进行亚组分析,用McNemar检验评估基于DAWN和DEFUSE 3入选标准筛选患者的一致性。

诊断标准与关键数值

  • 两种软件在时间至峰值>6秒体积、时间至峰值>10秒体积、CBF<30%体积、错配体积和错配比的Spearman相关系数分别为0.82、0.65、0.77、0.78、0.59;Wilcoxon符号秩检验P值分别为.30、.016、<.001、.03、<.001;单侧检验显示Viz.ai的CBF<30%体积更大(P<.001)。

临床应用与阅片要点

  • 作者结论指出,临床医生使用不同软件包进行临床决策时应谨慎。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Automated CTP postprocessing packages have been developed for managing acute ischemic stroke. These packages use image processing techniques to identify the ischemic core and penumbra. This study aimed to investigate the agreement of decision-making rules and output derived from RapidAI and Viz.ai software packages in early and late time windows and to identify predictors of inadequate quality CTP studies.

MATERIALS AND METHODS: One hundred twenty-nine patients with acute ischemic stroke who had CTP performed on presentation were analyzed by RapidAI and Viz.ai. Volumetric outputs were compared between packages by performing Spearman rank-order correlation and Wilcoxon signed-rank tests with subanalysis performed at early (<6 hours) and extended (>6 hours) time windows. The concordance of selecting patients on the basis of DAWN and DEFUSE 3 eligibility criteria was assessed using the McNemar test.

RESULTS: One hundred eight of 129 patients were found to have adequate-quality studies. Spearman rank-order correlation coefficients were calculated on time-to-maximum >6-second volume, time-to-maximum >10-second volume, CBF <30% volume, mismatch volume, and mismatch ratio between both software packages with correlation coefficients of 0.82, 0.65, 0.77, 0.78, 0.59, respectively. The Wilcoxon signed-rank test was also performed on time-to-maximum >6-second volume, time-to-maximum >10-second volume, CBF <30% volume, mismatch volume, and mismatch ratio with P values of .30, .016, <.001, .03, <.001, respectively. In a 1-sided test, CBF <30% was greater in Viz.ai (P < .001). Although this finding resulted in statistically significant differences, it did not cause clinically significant differences when applied to the DAWN and DEFUSE 3 criteria. A lower ejection fraction predicted an inadequate study in both software packages (P = .018; 95% CI, 0.01-0.113) and (P = .024; 95% CI, 0.008-0.109) for RapidAI and Viz.ai, respectively.

CONCLUSIONS: Penumbra and infarct core predictions between Rapid and Viz.ai correlated but were statistically different and resulted in equivalent triage using DAWN and DEFUSE3 criteria. Viz.ai predicted higher ischemic core volumes than RapidAI. Viz.ai predicted lower combined core and penumbra values than RapidAI at lower volumes and higher estimates than RapidAI at higher volumes. Clinicians should be cautious when using different software packages for clinical decision-making.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Bushnaq S, Hassan AE, Delora A, et al. A Comparison of CT Perfusion Output of RapidAI and Viz.ai Software in the Evaluation of Acute Ischemic Stroke. AJNR Am J Neuroradiol. 2024. PMID: 38346817. doi:10.3174/ajnr.A8196

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。